Showing results (831-840 of 3,350) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|October 13, 2010
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree modelEdward C F Wilson
Pharmacoeconomics|April 21, 2011
Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectivesNicole Mittmann, Paul Hernandez, Carl Mellström, et al.
Pharmacoeconomics|April 21, 2011
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrencePeter S Hall, Claire Hulme, Christopher McCabe, et al.
Pharmacoeconomics|April 9, 2011
Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorderArnie P Aldridge, Larry A Kroutil, Alexander J Cowell, et al.
Pharmacoeconomics|March 12, 2021
The EQ-5D-5L Valuation Study in EgyptSahar A Al Shabasy, Maggie M Abbassi, Aureliano Paolo Finch, et al.
Pharmacoeconomics|July 28, 2019
Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based CohortMichael Laxy, Verena Maria Schöning, Christoph Kurz, et al.
Pharmacoeconomics|August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerSteven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Pharmacoeconomics|November 14, 2013
Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluationsEdwin J M Oberjé, Reina J A de Kinderen, Silvia M A A Evers, et al.
Pharmacoeconomics|November 16, 2013
A methodological review of models used to estimate the cost effectiveness of antiretroviral regimens for the treatment of HIV infectionJosephine Mauskopf
Pharmacoeconomics|June 9, 2016
The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the EvidenceEleftherios Sideris, Mark Corbett, Stephen Palmer, et al.
Pageof 335